Establishment Labs Holdings Inc. (NASDAQ:ESTA) decreased considerably to $24.04. It was posted on Mar, 30 by Barchart.com. Establishment Labs Holdings Inc. (NASDAQ:ESTA) has $490.15 million market cap. At $23.32 price target, the company’s valuation could be $14.70M less.

For more Establishment Labs Holdings Inc. (NASDAQ:ESTA) news brought out recently go to: Businesswire.com, Nasdaq.com, Globenewswire.com, Globenewswire.com or Nasdaq.com. The titles are as follows: “KBW and Nasdaq Launch Financial Technology Index – Business Wire” brought out on July 18, 2016, “The IPO market has resumed being on fire with 11 new deals – Nasdaq” on July 10, 2018, “Establishment Labs announces transition to a Direct Sales Force in the United Kingdom – GlobeNewswire” with a publish date: September 04, 2018, “Establishment Labs Appoints Dennis Condon to the Board of Directors – GlobeNewswire” and the last “Establishment Labs to Present at the Cowen 39th Annual Health Care Conference – Nasdaq” with publication date: March 01, 2019.

Establishment Labs Holdings Inc., a medical technology company, designs, develops, makes, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology.The firm is worth $490.15 million. The firm primarily offers silicone gel-filled breast implants under Motiva Implants brand name.Last it reported negative earnings. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue.